EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Iran Pharmaceutical Local Manufacturing Market Review, 2004-2008

  • ID: 1215910
  • Report
  • March 2010
  • Region: Iran
  • 231 Pages
  • Iran Pharmaceutical Consulting Services
1 of 4

FEATURED COMPANIES

  • Cosar Pharmaceutical Co
  • Daana Pharmaceutical Co.
  • Exir Pharmaceutical Co.
  • Farabi Pharmaceutical Co.
  • Local manufacturers:
  • MORE
Locally manufactured pharmaceuticals are dominant in the pharmaceutical consumption market of Iran. The value of this market reached US$1.5 billion in 2008 with a compound annual growth rate of 20% from 2005 to 2008. Although it lost 6% of its market value share within this period and reached to 65% in 2008, yet in terms of volume it is still the market shaper. Generic production with low prices is the main practice of local manufacturers. They benefit from favored government's regulations, which are simultaneously persuading international and multinational companies to manufacture their products locally and benefit from its advantages.

Analyzed in a five-year period (2004-2008), this report provides the latest detailed information available on the market of locally manufactured pharmaceuticals and allows you to investigate trends in its different segments. Furthermore, it enables you to identify opportunities and growth sectors, spot your competition among local manufacturers and evaluate local manufacturing possibilities if interest your business.

The report's factual approach makes it an essential reference for decision makers in pharmaceutical companies that interested to enter and expand their business in Iran's fast growing market and benefit from its lucrative opportunities.

This report presented in 17 chapters and categorized information in two standpoints:

1 Total local manufacturing market review

In this section detailed historic information is provided, some of which are local production market size by anatomical main groups classified based on Anatomical Therapeutic Chemical (ATC) Classification System, top 10 classes in terms of value by second, third and forth level of ATC, market main dosage forms and top 10 local manufacturers of each group of dosage forms in terms of volume, top 20 pharmaceutical molecules, top 20 products and top 10 local pharmaceutical companies.

2 Local manufacturing market analysis by anatomical main groups of ATC

The report segments import market into 14 anatomical main groups of ATC, including:

1. Alimentary tract and metabolism
2. Blood and blood forming organs
3. Cardiovascular system
4. Dermatologicals
5. Genitourinary system and sex hormones
6. Systemic hormonal preparations (excluding sex hormones and insulins)
7. Anti-infectives for systemic use
8. Antineoplastic and immunomodulating agents
9. Musculoskeletal system
10. Nervous system
11. Antiparasitic products, insecticides and repellents
12. Respiratory system
13. Sensory organs
14. Various

For each of above groups, detailed historic information is provided some of which are main therapeutic groups, main dosage forms, top 10 pharmaceutical molecules, top 10 products, and top 10 local manufacturers.

Please note:
- This report only includes finished product market and does not cover raw materials and intermediary market.
- This report excludes dietary supplement market.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cosar Pharmaceutical Co
  • Daana Pharmaceutical Co.
  • Exir Pharmaceutical Co.
  • Farabi Pharmaceutical Co.
  • Local manufacturers:
  • MORE
Chapter 1. An overview of Iran pharmaceutical domestic market
- Quick look to local manufacturing market
- Pricing policy for locally manufactured pharmaceuticals
- Subsidy paid on pharmaceuticals
- Opportunities and challenges
- Summary
- Pharmaceutical local manufacturing market size
- Market of OTC and hospital products
- Market value by drug administration routes
- Market value by ATC anatomical main groups
- Market value growth by ATC anatomical main groups
- Top 10 therapeutic main groups
- Top 10 therapeutic/pharmacological subgroups
- Top 10 chemical/therapeutic/pharmacological subgroups
- Top 20 pharmaceutical molecules
- Top 20 pharmaceutical products

Chapter 2. Market review by main dosage forms
- Summary
- Market by main dosage forms
- Top 10 local manufacturers of capsules, pearls and tablets
- Top 10 local manufacturers of injections and infusions
- Top 10 local manufacturers of solutions, suspensions and syrups
- Top 10 local manufacturers of creams, ointments and gels
- Top 10 local manufacturers of drops
- Top local manufacturers of sprays and inhalers

Chapter 3. Domestic key players in the market
- Summary
- Top 10 local manufacturers
- Sales history of top 10 local manufacturers of 2008
- Top 10 import local manufacturers profile
- Darou Pakhsh Pharmaceutical Manufacturing Co.
- Farabi Pharmaceutical Co.
- Jaber Ebne Hayyan Pharmaceutical Co.
- Exir Pharmaceutical Co.
- Cosar Pharmaceutical Co.
- Tehran Chemie Pharmaceutical Co.
- Loghman Pharmaceutical & Hygienic Co.
- Daana Pharmaceutical Co.
- Alborz Darou Pharmaceutical Co.
- Chemi Darou Industrial Co.

Chapter 4. Therapy area analysis: Alimentary tract and metabolism
- Summary
- Therapeutic main groups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 10 local manufacturers

Chapter 5. Therapy area analysis: Blood and blood forming organs
- Summary
- Therapeutic main groups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 10 local manufacturers

Chapter 6. Therapy area analysis: Cardiovascular system
- Summary
- Therapeutic main groups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 10 local manufacturers

Chapter 7. Therapy area analysis: Dermatologicals
- Summary
- Therapeutic main groups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 10 local manufacturers

Chapter 8. Therapy area analysis: Genitourinary system and sex hormones
- Summary
- Therapeutic main groups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 10 local manufacturers

Chapter 9. Therapy area analysis: Systemic hormonal preparations
- Summary
- Therapeutic main groups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 10 local manufacturers

Chapter 10. Therapy area analysis: Anti-infectives for systemic use
- Summary
- Therapeutic main groups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 10 local manufacturers

Chapter 11. Therapy area analysis: Antineoplastic and immunomodulating agents
- Summary
- Therapeutic main groups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 10 local manufacturers

Chapter 12. Therapy area analysis: Musculoskeletal system
- Summary
- Therapeutic main groups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 10 local manufacturers

Chapter 13. Therapy area analysis: Nervous system
- Summary
- Therapeutic main groups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 10 local manufacturers

Chapter 14. Therapy area analysis: Antiparasitic products, insecticides and repellents
- Summary
- Therapeutic main groups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 10 local manufacturers

Chapter 15. Therapy area analysis: Respiratory system
- Summary
- Therapeutic main groups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 10 local manufacturers

Chapter 16. Therapy area analysis: Sensory organs
- Summary
- Therapeutic main groups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 7 Local manufacturers

Chapter 17. Therapy area analysis: Various
- Summary
- Main subgroups
- Main dosage forms
- Top 10 pharmaceutical molecules
- Top 10 pharmaceutical products
- Top 10 local manufacturers

List of tables

Table 1.1. Iran pharmaceutical local manufacturing market value and volume, 2004-2008
Table 1.2. Hospital and OTC drugs local manufacturing market size, 2008
Table 1.3. Pharmaceutical local manufacturing market by routes of administration of drugs, 2004-2008
Table 1.4. Local manufacturing market size by first level of ATC code (anatomical main groups), 2004-2008
Table 1.5. Local manufacturing market value annual % change by first level of ATC code (anatomical main groups), 2004-2008
Table 1.6. Local manufacturing market top 10 by second level of ATC code (therapeutic main groups), 2004-2008
Table 1.7. Local manufacturing market top 10 by third level of ATC code (therapeutic/pharmacological subgroups), 2004-2008
Table 1.8. Local manufacturing market top 10 by fourth level of ATC code (chemical/therapeutic /pharmacological subgroups), 2004-2008
Table 1.9. Top 20 locally manufactured pharmaceutical molecules by value, 2004-2008
Table 1.10. Top 20 locally manufactured pharmaceutical products by value, 2004-2008
Table 2.1. Value and volume of locally manufactured main dosage forms, 2004-2008
Table 2.2. Top 10 local manufacturers in terms of volume for the dosage form group of capsules, pearls and tablets, 2004-2008
Table 2.3. Top 10 local manufacturers in terms of volume for the dosage form group of injections and infusions, 2004-2008
Table 2.4. Top 10 local manufacturers in terms of volume for the dosage form group of solutions, suspensions and syrups, 2004-2008
Table 2.5. Top 10 local manufacturers in terms of volume for the dosage form group of creams, ointments and gels, 2004-2008
Table 2.6. Top 10 local manufacturers in terms of volume for the dosage form group of drops, 2004-2008
Table 2.7. Local manufacturers in terms of volume for the dosage form group of sprays and inhalers, 2004-2008
Table 3.1. Top 10 local manufacturers by market sales value, 2004-2008
Table 3.2. Top 10 local manufacturers of 2008, five year trend in market sales value, 2004-2008
Table 3.3. Darou Pakhsh Pharmaceutical Manufacturing Co. market sales value, 2004-2008
Table 3.4. Darou Pakhsh Pharmaceutical Manufacturing Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.5. Value and volume of main dosage forms manufactured by Darou Pakhsh Pharmaceutical Manufacturing Co., 2004-2008
Table 3.6. Farabi Pharmaceutical Co. market sales value, 2004-2008
Table 3.7. Farabi Pharmaceutical Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.8. Value and volume of main dosage forms manufactured by Farabi Pharmaceutical Co., 2004-2008
Table 3.9. Jaber Ebne Hayyan Pharmaceutical Co. market sales value, 2004-2008
Table 3.10. Jaber Ebne Hayyan Pharmaceutical Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.11. Value and volume of main dosage forms manufactured by Jaber Ebne Hayyan Pharmaceutical Co., 2004-2008
Table 3.12. Exir Pharmaceutical Co. market sales value, 2004-2008
Table 3.13. Exir Pharmaceutical Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.14. Value and volume of main dosage forms manufactured by Exir Pharmaceutical Co., 2004-2008
Table 3.15. Cosar Pharmaceutical Co. market sales value, 2004-2008
Table 3.16. Cosar Pharmaceutical Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.17. Value and volume of main dosage forms manufactured by Cosar Pharmaceutical Co., 2004-2008
Table 3.18. Tehran Chemie Pharmaceutical Co. market sales value, 2004-2008
Table 3.19. Tehran Chemie Pharmaceutical Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.20. Value and volume of main dosage forms manufactured by Tehran Chemie Pharmaceutical Co., 2004-2008
Table 3.21. Loghman Pharmaceutical & Hygienic Co. market sales value, 2004-2008
Table 3.22. Loghman Pharmaceutical & Hygienic Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.23. Value and volume of main dosage forms manufactured by Loghman Pharmaceutical & Hygienic Co., 2004-2008
Table 3.24. Daana Pharmaceutical Co. market sales value, 2004-2008
Table 3.25. Daana Pharmaceutica Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.26. Value and volume of main dosage forms manufactured by Daana Pharmaceutical Co., 2004-2008
Table 3.27. Alborz Darou Pharmaceutical Co. market sales value, 2004-2008
Table 3.28. Alborz Darou Pharmaceutical Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.29. Value and volume of main dosage forms manufactured by Alborz Darou Pharmaceutical Co., 2004-2008
Table 3.30. Chemi Darou Industrial Co. market sales value, 2004-2008
Table 3.31. Chemi Darou Industrial Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.32. Value and volume of main dosage forms manufactured by Chemi Darou Industrial Co., 2004-2008
Table 4.1. Local manufacturing market value of pharmaceuticals for Alimentary tract & metabolism, 2004-2008
Table 4.2. Local manufacturing market value of pharmaceuticals for Alimentary tract & metabolism by second level of ATC code (therapeutic main groups), 2004-2008
Table 4.3. Local manufacturing market by main dosage forms of pharmaceuticals for Alimentary tract & metabolism, 2004-2008
Table 4.4. Top 10 locally manufactured pharmaceutical molecules for Alimentary tract & metabolism, 2004-2008
Table 4.5. Top 10 locally manufactured pharmaceutical products for Alimentary tract & metabolism, 2004-2008
Table 4.6. Top 10 local manufacturers of pharmaceuticals for Alimentary tract & metabolism, 2004-2008
Table 5.1. Local manufacturing market value of pharmaceuticals for Blood & blood forming organs, 2004-2008
Table 5.2. Local manufacturing market value of pharmaceuticals for Blood & blood forming organs by second level of ATC code (therapeutic main groups), 2004-2008
Table 5.3. Local manufacturing market by main dosage forms of pharmaceuticals for Blood & blood forming organs, 2004-2008
Table 5.4. Top 10 locally manufactured pharmaceutical molecules for Blood & blood forming organs, 2004-2008
Table 5.5. Top 10 locally manufactured pharmaceutical products for Blood & blood forming organs, 2004-2008
Table 5.6. Top 10 local manufacturers of pharmaceuticals for Blood & blood forming organs, 2004-2008
Table 6.1. Local manufacturing market value of pharmaceuticals for Cardiovascular system, 2004-2008
Table 6.2. Local manufacturing market value of pharmaceuticals for Cardiovascular system by second level of ATC code (therapeutic main groups), 2004-2008
Table 6.3. Local manufacturing market by main dosage forms of pharmaceuticals for Cardiovascular system, 2004-2008
Table 6.4. Top 10 locally manufactured pharmaceutical molecules for Cardiovascular system, 2004-2008
Table 6.5. Top 10 locally manufactured pharmaceutical products for Cardiovascular system, 2004-2008
Table 6.6. Top 10 local manufacturers of pharmaceuticals for Cardiovascular system, 2004-2008
Table 7.1. Local manufacturing market value of Dermatologicals, 2004-2008
Table 7.2. Local manufacturing market value of Dermatologicals by second level of ATC code (therapeutic main groups), 2004-2008
Table 7.3. Local manufacturing market by main dosage forms of Dermatologicals, 2004-2008
Table 7.4. Top 10 locally manufactured pharmaceutical molecules of Dermatologicals, 2004-2008
Table 7.5. Top 10 locally manufactured pharmaceutical products of Dermatologicals, 2004-2008
Table 7.6. Top 10 local manufacturers of Dermatologicals, 2004-2008
Table 8.1. Local manufacturing market value of pharmaceuticals for Genitourinary system & sex hormones, 2004-2008
Table 8.2. Local manufacturing market value of pharmaceuticals for Genitourinary system & sex hormones by second level of ATC code (therapeutic main groups), 2004-2008
Table 8.3. Local manufacturing market by main dosage forms of pharmaceuticals for Genitourinary system & sex hormones, 2004-2008
Table 8.4. Top 10 locally manufactured pharmaceutical molecules for Genitourinary system & sex hormones, 2004-2008
Table 8.5. Top 10 locally manufactured pharmaceutical products for Genitourinary system & sex hormones, 2004-2008
Table 8.6. Top 10 local manufacturers of pharmaceuticals for Genitourinary system & sex hormones, 2004-2008
Table 9.1. Local manufacturing market value of Systemic hormonal preparations, 2004-2008
Table 9.2. Local manufacturing market value of Systemic hormonal preparations by second level of ATC code (therapeutic main groups), 2004-2008
Table 9.3. Local manufacturing market by main dosage forms of Systemic hormonal preparations, 2004-2008
Table 9.4. Top 10 locally manufactured pharmaceutical molecules of Systemic hormonal preparations, 2004-2008
Table 9.5. Top 10 locally manufactured pharmaceutical productas of Systemic hormonal preparations, 2004-2008
Table 9.6. Top 10 local manufacturers of Systemic hormonal preparations, 2004-2008
Table 10.1. Local manufacturing market value of Anti-infectives for systemic use, 2004-2008
Table 10.2. Local manufacturing market value of Anti-infectives for systemic use by second level of ATC code (therapeutic main groups), 2004-2008
Table 10.3. Local manufacturing market by main dosage forms of Anti-infectives for systemic use, 2004-2008
Table 10.4. Top 10 locally manufactured pharmaceutical molecules of Anti-infectives for systemic use, 2004-2008
Table 10.5. Top 10 locally manufactured pharmaceutical products of Anti-infectives for systemic use, 2004-2008
Table 10.6. Top 10 local manufacturers of Anti-infectives for systemic use, 2004-2008
Table 11.1. Local manufacturing market value of Antineoplastic & immunomodulating agents, 2004-2008
Table 11.2. Local manufacturing market value of Antineoplastic & immunomodulating agents by second level of ATC code (therapeutic main groups), 2004-2008
Table 11.3. Local manufacturing market by main dosage forms of Antineoplastic & immunomodulating agents, 2004-2008
Table 11.4. Top 10 locally manufactured pharmaceutical molecules of Antineoplastic & immunomodulating agents, 2004-2008
Table 11.5. Top 10 locally manufactured pharmaceutical products of Antineoplastic & immunomodulating agents, 2004-2008
Table 11.6. Top 10 local manufacturers of Antineoplastic & immunomodulating agents, 2004-2008
Table 12.1. Local manufacturing market value of pharmaceuticals for Musculoskeletal system, 2004-2008
Table 12.2. Local manufacturing market value of pharmaceuticals for Musculoskeletal system by second level of ATC code (therapeutic main groups), 2004-2008
Table 12.3. Local manufacturing market by main dosage forms of pharmaceuticals for Musculoskeletal system, 2004-2008
Table 12.4. Top 10 locally manufactured pharmaceutical molecules for Musculoskeletal system, 2004-2008
Table 12.5. Top 10 locally manufactured pharmaceutical products for Musculoskeletal system, 2004-2008
Table 12.6. Top 10 local manufacturers of pharmaceuticals for Musculoskeletal system, 2004-2008
Table 13.1. Local manufacturing market value of pharmaceuticals for Nervous system, 2004-2008
Table 13.2. Local manufacturing market value of pharmaceuticals for Nervous system by second level of ATC code (therapeutic main groups), 2004-2008
Table 13.3. Local manufacturing market by main dosage forms of pharmaceuticals for Nervous system, 2004-2008
Table 13.4. Top 10 locally manufactured pharmaceutical molecules for Nervous system, 2004-2008
Table 13.5. Top 10 locally manufactured pharmaceutical products for Nervous system, 2004-2008
Table 13.6. Top 10 local manufacturers of pharmaceuticals for Nervous system, 2004-2008
Table 14.1. Local manufacturing market value of Antiparasitics, insecticides & repellents, 2004-2008
Table 14.2. Local manufacturing market value of Antiparasitics, insecticides & repellents by second level of ATC code (therapeutic main groups), 2004-2008
Table 14.3. Local manufacturing market by main dosage forms of Antiparasitics, insecticides & repellents, 2004-2008
Table 14.4. Top 10 locally manufactured pharmaceutical molecules of Antiparasitics, insecticides & repellents, 2004-2008
Table 14.5. Top 10 locally manufactured pharmaceutical products of Antiparasitics, insecticides & repellents, 2004-2008
Table 14.6. Top 10 local manufacturers of Antiparasitics, insecticides & repellents, 2004-2008
Table 15.1. Local manufacturing market value of pharmaceuticals for Respiratory system, 2004-2008
Table 15.2. Local manufacturing market value of pharmaceuticals for Respiratory system by second level of ATC code (therapeutic main groups), 2004-2008
Table 15.3. Local manufacturing market by main dosage forms of pharmaceuticals for Respiratory system, 2004-2008
Table 15.4. Top 10 locally manufactured pharmaceutical molecules for Respiratory system, 2004-2008
Table 15.5. Top 10 locally manufactured pharmaceutical products for Respiratory system, 2004-2008
Table 15.6. Top 10 local manufacturers of pharmaceuticals for Respiratory system, 2004-2008
Table 16.1. Local manufacturing market value of pharmaceuticals for Sensory organs, 2004-2008
Table 16.2. Local manufacturing market value of pharmaceuticals for Sensory organs by second level of ATC code (therapeutic main groups), 2004-2008
Table 16.3. Local manufacturing market by main dosage forms of pharmaceuticals for Sensory organs, 2004-2008
Table 16.4. Top 10 locally manufactured pharmaceutical molecules for Sensory organs, 2004-2008
Table 16.5. Top 10 locally manufactured pharmaceutical products for Sensory organs, 2004-2008
Table 16.6. Top 7 local manufacturers of pharmaceuticals for Sensory organs, 2004-2008
Table 17.1. Various category local manufacturing market value, 2004-2008
Table 17.2. Various category local manufacturing market value by second level of ATC code (therapeutic main groups), 2004-2008
Table 17.3. Local manufacturing market by main dosage forms of pharmaceuticals belong to Various category, 2004-2008
Table 17.4. Top 10 locally manufactured pharmaceutical molecules of Various category, 2004-2008
Table 17.5. Top 10 locally manufactured pharmaceutical products of Various category, 2004-2008
Table 17.6. Top 10 local manufacturers of pharmaceutical products for Various category, 2004-2008
Note: Product cover images may vary from those shown
3 of 4
Local manufacturers:

- Darou Pakhsh Pharmaceutical Manufacturing Co.
- Farabi Pharmaceutical Co.
- Jaber Ebne Hayyan Pharmaceutical Co.
- Exir Pharmaceutical Co.
- Cosar Pharmaceutical Co
- Tehran Chemie Pharmaceutical Co.
- Loghman Pharmaceutical & Hygienic Co.
- Daana Pharmaceutical Co.
- Alborz Darou Pharmaceutical Co.
- Chemi Darou Industrial Co.
Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll